Profil
Miguel Sieler was the founder of Abivax SA, serving as Director from 2003 to 2015.
Mr. Sieler is currently President & Director at Neovacs, Inc. Former positions include Chief Executive Officer & Director at Neovacs SA from 2013 to 2019, Chief Executive Officer at Bayer Pharma France SA, Chairman-Supervisory Board at Haarmann & Reimer Corp, Deputy Chairman-Supervisory Board at Borchers SAS, Chairman at Wittycell SAS from 2009 to 2014, Chairman-Supervisory Board at Bayer Sante Familiale SAS, Chairman-Management Board at Bayer SAS, Chairman-Supervisory Board at Bayer Sante, Chairman-Supervisory Board at ARLANXEO Elastomères France SAS, Chairman at Demeta SAS, Chairman at Natchem SASU, Director at Ethypharm SAS, Independent Director at Nexity SA from 2012 to 2016, Director at Fondation de la Maison de la Chimie, Director at Bayer Environmental Science SAS, Director at Bayer Immobilier, Director at Bayer HealthCare Ltd., Member-Supervisory Board at Bayer CropScience SA, President at Plasmaprime SAS from 2010 to 2012, Member-Supervisory Board at Lanxess SAS, and Venture Partner at Truffle Capital SAS from 2011 to 2016.
Education includes a graduate degree from Eberhard Karls Universität Tübingen and an undergraduate degree from Sciences Po.
Postes actifs de Miguel Sieler
| Sociétés | Poste | Début |
|---|---|---|
Neovacs, Inc.
Neovacs, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies | President | - |
Anciens postes connus de Miguel Sieler
| Sociétés | Poste | Fin |
|---|---|---|
| NEOVACS | Directeur Général | 30/09/2019 |
| NEXITY | Directeur/Membre du Conseil | 12/12/2016 |
Truffle Capital SAS
Truffle Capital SAS Investment ManagersFinance Truffle Capital invests in companies located in France with revenues of EUR 5 million. The firm focuses on life sciences (medtech & biotech) and deeptech applied to finance (fintech & Insurtech) sectors. It provides financing for early stage capital requirements with an investment size of EUR 5 - 15 million. It acts as a lead investor and it takes a seat on the board of directors. The firm makes follow-on investments. | Analyste en capital-investissement | 01/01/2016 |
| ABIVAX | Fondateur | 06/09/2015 |
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Develops vaccine products & solutions | Président | 01/07/2014 |
Formation de Miguel Sieler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Haarmann & Reimer Corp
Haarmann & Reimer Corp Food: Specialty/CandyConsumer Non-Durables Manufactures flavours and fragrances | Consumer Non-Durables |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for severe pain and addiction | Health Technology |
Nexity SA
Nexity SA Real Estate DevelopmentFinance Provides real estate letting, management and investment services | Finance |
Neovacs SA
Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
Bayer CropScience SA
Bayer CropScience SA BiotechnologyHealth Technology Offers crop protection, non agricultural pest-control products | Health Technology |
Eberhard Karls Universität Tübingen
Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sciences Po
Sciences Po Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fondation de la Maison de la Chimie | |
Truffle Capital SAS
Truffle Capital SAS Investment ManagersFinance Truffle Capital invests in companies located in France with revenues of EUR 5 million. The firm focuses on life sciences (medtech & biotech) and deeptech applied to finance (fintech & Insurtech) sectors. It provides financing for early stage capital requirements with an investment size of EUR 5 - 15 million. It acts as a lead investor and it takes a seat on the board of directors. The firm makes follow-on investments. | Finance |
Borchers SAS
Borchers SAS Industrial SpecialtiesProcess Industries Produces paints, lacquers and polishes | Process Industries |
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Develops vaccine products & solutions | Health Technology |
Bayer Pharma France SA
Bayer Pharma France SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Plasmaprime SAS
Plasmaprime SAS Medical/Nursing ServicesHealth Services Provides plasma derived drugs collected from blood transfusion centers | Health Services |
Bayer Sante Familiale SAS
Bayer Sante Familiale SAS Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Bayer SAS
Bayer SAS Drugstore ChainsRetail Trade Engages in research, development and marketing of pharmaceutical products | Retail Trade |
Bayer Sante | |
ARLANXEO Elastomères France SAS
ARLANXEO Elastomères France SAS Chemicals: SpecialtyProcess Industries Manufactures synthetic rubber | Process Industries |
Bayer Environmental Science SAS
Bayer Environmental Science SAS Wholesale DistributorsDistribution Services Wholesales chemical products | Distribution Services |
Lanxess SAS
Lanxess SAS Chemicals: Major DiversifiedProcess Industries Engages in producing, developing and marketing chemical intermediates, additives, specialty chemicals and plastics | Process Industries |
Bayer Immobilier
Bayer Immobilier Real Estate DevelopmentFinance Rents of land and immovable property's | Finance |
Demeta SAS
Demeta SAS Chemicals: Major DiversifiedProcess Industries Develops catalysts for the production and marketing of high-performance materials & chemicals | Process Industries |
Natchem SASU
Natchem SASU BiotechnologyHealth Technology Engages in research and development that focuses on biotechnology | Health Technology |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Bayer HealthCare Ltd. | |
Neovacs, Inc.
Neovacs, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies | Health Technology |
















